ONCORUS Misses Earnings Expectations by $0.48 per Share
☀️Trending News Oncorus ($NASDAQ:ONCR), an immuno-oncology company focused on leveraging the power of the immune system to fight cancer, recently [...]
Oncorus Intrinsic Value Calculation – ONCORUS Facing Bankruptcy as 43% of Employees Laid Off
🌥️Trending News Oncorus ($NASDAQ:ONCR) is a publicly-traded biotechnology company dedicated to the discovery and development of innovative treatments and cures [...]
